These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15520858)

  • 1. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.
    Bielenberg DR; Hida Y; Shimizu A; Kaipainen A; Kreuter M; Kim CC; Klagsbrun M
    J Clin Invest; 2004 Nov; 114(9):1260-71. PubMed ID: 15520858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis.
    Zhang B; Gao Z; Sun M; Li H; Fan H; Chen D; Zheng J
    J Surg Oncol; 2015 Mar; 111(4):382-8. PubMed ID: 25475162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells.
    Kusy S; Nasarre P; Chan D; Potiron V; Meyronet D; Gemmill RM; Constantin B; Drabkin HA; Roche J
    Neoplasia; 2005 May; 7(5):457-65. PubMed ID: 15967098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.
    Futamura M; Kamino H; Miyamoto Y; Kitamura N; Nakamura Y; Ohnishi S; Masuda Y; Arakawa H
    Cancer Res; 2007 Feb; 67(4):1451-60. PubMed ID: 17308083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of mTOR Signaling by Semaphorin 3F-Neuropilin 2 Interactions In Vitro and In Vivo.
    Nakayama H; Bruneau S; Kochupurakkal N; Coma S; Briscoe DM; Klagsbrun M
    Sci Rep; 2015 Jul; 5():11789. PubMed ID: 26156437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion.
    Nasarre P; Kusy S; Constantin B; Castellani V; Drabkin HA; Bagnard D; Roche J
    Neoplasia; 2005 Feb; 7(2):180-9. PubMed ID: 15802023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2.
    Coma S; Shimizu A; Klagsbrun M
    Cell Adh Migr; 2011; 5(3):266-75. PubMed ID: 21610314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
    Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
    Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 3F Promotes Transendothelial Migration of Leukocytes in the Inflammatory Response After Survived Cardiac Arrest.
    Reichert S; Scheid S; Roth T; Herkel M; Petrova D; Linden A; Weberbauer M; Esser J; Diehl P; Grundmann S; Busch HJ; Fink K; Bode C; Moser M; Helbing T
    Inflammation; 2019 Aug; 42(4):1252-1264. PubMed ID: 30877507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.
    Joseph D; Ho SM; Syed V
    Mol Cancer Ther; 2010 Feb; 9(2):499-509. PubMed ID: 20124444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells.
    Bielenberg DR; Shimizu A; Klagsbrun M
    Methods Enzymol; 2008; 443():299-314. PubMed ID: 18772022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that Sema3A and Sema3F regulate the migration of GABAergic neurons in the developing neocortex.
    Tamamaki N; Fujimori K; Nojyo Y; Kaneko T; Takauji R
    J Comp Neurol; 2003 Jan; 455(2):238-48. PubMed ID: 12454988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semaphorin 3F is critical for development of limbic system circuitry and is required in neurons for selective CNS axon guidance events.
    Sahay A; Molliver ME; Ginty DD; Kolodkin AL
    J Neurosci; 2003 Jul; 23(17):6671-80. PubMed ID: 12890759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorin 3F and neuropilin-2 control the migration of human T-cell precursors.
    Mendes-da-Cruz DA; Brignier AC; Asnafi V; Baleydier F; Messias CV; Lepelletier Y; Bedjaoui N; Renand A; Smaniotto S; Canioni D; Milpied P; Balabanian K; Bousso P; Leprêtre S; Bertrand Y; Dombret H; Ifrah N; Dardenne M; Macintyre E; Savino W; Hermine O
    PLoS One; 2014; 9(7):e103405. PubMed ID: 25068647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
    Zhou ZH; Rao J; Yang J; Wu F; Tan J; Xu SL; Ding Y; Zhan N; Hu XG; Cui YH; Zhang X; Dong W; Liu XD; Bian XW
    J Pathol; 2015 Aug; 236(4):467-78. PubMed ID: 25866254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients.
    Ong HS; Gokavarapu S; Xu Q; Tian Z; Li J; Ji T; Zhang CP
    Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1205-1219. PubMed ID: 28602571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
    Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
    Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.